Rapid Nutrition（ALRPD）株式概要ナチュラルヘルスケア企業であるラピッドニュートリションPLCは、科学的根拠に基づいた健康とウェルネス製品を開発し、世界中で販売している。 詳細ALRPD ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性6/6配当金0/6リスク分析収益が 100 万ドル未満 ( A$194K )意味のある時価総額がありません ( €3M )French市場と比較して、過去 3 か月間の株価の変動が非常に大きいすべてのリスクチェックを見るALRPD Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW488,086 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA488,086 investors already sharing narrativesYour Fair Value€Current Price€6.817.8k% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-10m5m2016201920222025202620282031Revenue AU$46.9kEarnings AU$4.9kAdvancedSet Fair ValueView all narrativesRapid Nutrition PLC 競合他社Jacques BogartSymbol: ENXTPA:JBOGMarket cap: €34.8mIEVA GroupSymbol: ENXTPA:ALIEVMarket cap: €90.4mParanovus Entertainment TechnologySymbol: NasdaqCM:PAVSMarket cap: US$2.5mHydration PharmaceuticalsSymbol: ASX:HPCMarket cap: AU$2.1m価格と性能株価の高値、安値、推移の概要Rapid Nutrition過去の株価現在の株価€6.8152週高値€15.0052週安値€2.40ベータ-0.421ヶ月の変化5.58%3ヶ月変化-45.95%1年変化-1.30%3年間の変化-99.15%5年間の変化-99.90%IPOからの変化-99.90%最新ニュースお知らせ • Jun 02Rapid Nutrition Expands Agentic AI Integration Across Consumer Wellness EcosystemRapid Nutrition PLC has progressively expanded the rollout of its technology-enabled engagement platform across investor communications, consumer wellness interactions and broader digital operations as part of its strategy to build a scalable HealthTech ecosystem at the intersection of nutrition, technology and consumer behaviour. Following the initial deployment across investor communications, Rapid Nutrition has observed improved accessibility and responsiveness, with investor enquiries increasingly being addressed in near real-time across multiple time zones. The Company has since expanded the platform across elements of its consumer ecosystem, including the Company’s flagship SystemLS brand, where early-stage engagement trends indicate increasing interaction with product, wellness and lifestyle-aligned content tailored to individual user interests and behaviours. Rapid Nutrition believes the application of artificial intelligence and agentic capabilities enables a transition from static information delivery toward more responsive, real-time and personalized engagement across both investor and consumer channels. The platform has been developed using Company materials and operational frameworks and continues to be refined by Rapid Nutrition’s experienced team to ensure alignment with the Company’s products, communication standards and broader wellness ecosystem.お知らせ • May 13Rapid Nutrition plc Expands AI-Powered Agentic Platform to Consumer EcosystemRapid Nutrition PLC announced the expansion of its technology platform to its consumer-facing ecosystem, following a successful rollout within its investor communications infrastructure. The Company is extending these capabilities across its flagship SystemLS brand, enabling a more responsive and personalized approach to consumer health and wellness engagement. The platform delivers structured, on-demand guidance across nutrition, products, and lifestyle — available 24/7 in a private, confidential environment. As consumer expectations increasingly flavor personalized health solutions, the system is designed to translate product and nutritional information into practical, everyday guidance aligned to individual habits and routines. Trained on Company materials and informed by Rapid Nutrition’s experienced team, the platform ensures all responses reflect the Company’s product philosophy, nutritional methodologies, and established wellness programs. The system is designed to complement, not replace, professional human interaction — extending access to practitioner-informed guidance while maintaining alignment with the Company’s personalised nutrition approach. It supports consumer education only and does not constitute professional medical advice. This expansion represents a continued step in Rapid Nutrition’s strategy to deploy advanced technologies — including artificial intelligence and agentic capabilities — across both its corporate and consumer operations, driving deeper and more consistent engagement with long-term wellness programs.Reported Earnings • Apr 30Full year 2025 earnings released: AU$0.01 loss per share (vs AU$38.10 loss in FY 2024)Full year 2025 results: AU$0.01 loss per share. Net loss: AU$3.10m (loss widened 6.8% from FY 2024).お知らせ • Apr 22Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia.Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia on April 20, 2026. The transaction is subject to consummation of due diligence investigation and final documentation.Board Change • Apr 13Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Buy Or Sell Opportunity • Feb 10Now 29% undervaluedOver the last 90 days, the stock has risen 237% to €10.12. The fair value is estimated to be €14.25, however this is not to be taken as a buy recommendation but rather should be used as a guide only.最新情報をもっと見るRecent updatesお知らせ • Jun 02Rapid Nutrition Expands Agentic AI Integration Across Consumer Wellness EcosystemRapid Nutrition PLC has progressively expanded the rollout of its technology-enabled engagement platform across investor communications, consumer wellness interactions and broader digital operations as part of its strategy to build a scalable HealthTech ecosystem at the intersection of nutrition, technology and consumer behaviour. Following the initial deployment across investor communications, Rapid Nutrition has observed improved accessibility and responsiveness, with investor enquiries increasingly being addressed in near real-time across multiple time zones. The Company has since expanded the platform across elements of its consumer ecosystem, including the Company’s flagship SystemLS brand, where early-stage engagement trends indicate increasing interaction with product, wellness and lifestyle-aligned content tailored to individual user interests and behaviours. Rapid Nutrition believes the application of artificial intelligence and agentic capabilities enables a transition from static information delivery toward more responsive, real-time and personalized engagement across both investor and consumer channels. The platform has been developed using Company materials and operational frameworks and continues to be refined by Rapid Nutrition’s experienced team to ensure alignment with the Company’s products, communication standards and broader wellness ecosystem.お知らせ • May 13Rapid Nutrition plc Expands AI-Powered Agentic Platform to Consumer EcosystemRapid Nutrition PLC announced the expansion of its technology platform to its consumer-facing ecosystem, following a successful rollout within its investor communications infrastructure. The Company is extending these capabilities across its flagship SystemLS brand, enabling a more responsive and personalized approach to consumer health and wellness engagement. The platform delivers structured, on-demand guidance across nutrition, products, and lifestyle — available 24/7 in a private, confidential environment. As consumer expectations increasingly flavor personalized health solutions, the system is designed to translate product and nutritional information into practical, everyday guidance aligned to individual habits and routines. Trained on Company materials and informed by Rapid Nutrition’s experienced team, the platform ensures all responses reflect the Company’s product philosophy, nutritional methodologies, and established wellness programs. The system is designed to complement, not replace, professional human interaction — extending access to practitioner-informed guidance while maintaining alignment with the Company’s personalised nutrition approach. It supports consumer education only and does not constitute professional medical advice. This expansion represents a continued step in Rapid Nutrition’s strategy to deploy advanced technologies — including artificial intelligence and agentic capabilities — across both its corporate and consumer operations, driving deeper and more consistent engagement with long-term wellness programs.Reported Earnings • Apr 30Full year 2025 earnings released: AU$0.01 loss per share (vs AU$38.10 loss in FY 2024)Full year 2025 results: AU$0.01 loss per share. Net loss: AU$3.10m (loss widened 6.8% from FY 2024).お知らせ • Apr 22Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia.Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia on April 20, 2026. The transaction is subject to consummation of due diligence investigation and final documentation.Board Change • Apr 13Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Buy Or Sell Opportunity • Feb 10Now 29% undervaluedOver the last 90 days, the stock has risen 237% to €10.12. The fair value is estimated to be €14.25, however this is not to be taken as a buy recommendation but rather should be used as a guide only.Buy Or Sell Opportunity • Jan 22Now 35,009% overvalued after recent price riseOver the last 90 days, the stock has risen 124,224% to €4.60. The fair value is estimated to be €0.013, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 41% over the last 3 years. Meanwhile, the company became loss making.お知らせ • Jan 05Rapid Nutrition PLC announced that it has received €5 million in fundingRapid Nutrition PLC announced a private placement of common shares for gross proceeds of €5 million on January 5, 2026.Reported Earnings • Oct 29First half 2025 earnings released: EPS: AU$0 (vs AU$0 in 1H 2024)First half 2025 results: EPS: AU$0 (in line with 1H 2024). Revenue: AU$113.1k (down 59% from 1H 2024). Net loss: AU$1.65m (loss narrowed 17% from 1H 2024). Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Personal Products industry in Europe.New Risk • Oct 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 17% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 7x increase in shares outstanding). Revenue is less than US$1m (AU$917k revenue, or US$594k). Market cap is less than US$10m (€2.14m market cap, or US$2.50m). Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Share price has been volatile over the past 3 months (9.7% average weekly change).New Risk • Dec 13New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.9m free cash flow). Share price has been highly volatile over the past 3 months (41% average weekly change). Earnings have declined by 34% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 18x increase in shares outstanding). Revenue is less than US$1m (AU$1.3m revenue, or US$816k). Market cap is less than US$10m (€3.19m market cap, or US$3.35m).Reported Earnings • Oct 24First half 2024 earnings releasedFirst half 2024 results: EPS: AU$0. Revenue: AU$276.1k (down 58% from 1H 2023). Net loss: AU$1.99m (loss widened 117% from 1H 2023). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Personal Products industry in Europe.Reported Earnings • May 01Full year 2023 earnings released: AU$0.001 loss per share (vs AU$18.64 loss in FY 2022)Full year 2023 results: AU$0.001 loss per share (improved from AU$18.64 loss in FY 2022). Revenue: AU$1.66m (down 44% from FY 2022). Net loss: AU$2.02m (loss narrowed 80% from FY 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe.New Risk • Apr 28New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (28% average weekly change). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 39x increase in shares outstanding). Market cap is less than US$10m (€1.43m market cap, or US$1.53m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Revenue is less than US$5m (AU$3.2m revenue, or US$2.1m).New Risk • Oct 18New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.0m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.0m free cash flow). Share price has been highly volatile over the past 3 months (34% average weekly change). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 6x increase in shares outstanding). Market cap is less than US$10m (€482.9k market cap, or US$508.5k). Minor Risk Revenue is less than US$5m (AU$3.2m revenue, or US$2.1m).New Risk • Jun 29New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (53% average weekly change). Earnings have declined by 56% per year over the past 5 years. Shareholders have been substantially diluted in the past year (162% increase in shares outstanding). Market cap is less than US$10m (€374.5k market cap, or US$408.8k). Minor Risk Revenue is less than US$5m (AU$3.0m revenue, or US$2.0m).Reported Earnings • Jun 29Full year 2022 earnings released: AU$0.002 loss per share (vs AU$0.005 profit in FY 2021)Full year 2022 results: AU$0.002 loss per share (down from AU$0.005 profit in FY 2021). Revenue: AU$2.96m (down 1.5% from FY 2021). Net loss: AU$9.97m (down AU$10.2m from profit in FY 2021). Revenue is forecast to grow 7.9% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 05First half 2022 earnings released: EPS: AU$0.007 (vs AU$0.009 in 1H 2021)First half 2022 results: EPS: AU$0.007. Revenue: AU$1.99m (up 42% from 1H 2021). Net income: AU$1.07m (up 196% from 1H 2021). Profit margin: 54% (up from 26% in 1H 2021). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Personal Products industry in Europe.お知らせ • May 31Rapid Nutrition PLC (ENXTPA:ALRPD) acquired Silveraxe LLP for approximately USD 0.75 million.Rapid Nutrition PLC (ENXTPA:ALRPD) acquired Silveraxe LLP for approximately USD 0.75 million on May 30, 2022. Rapid Nutrition PLC (ENXTPA:ALRPD) completed the acquisition of Silveraxe LLP on May 30, 2022.お知らせ • May 25Rapid Nutrition PLC, Annual General Meeting, Jun 30, 2022Rapid Nutrition PLC, Annual General Meeting, Jun 30, 2022, at 21:00 Coordinated Universal Time. Location: 2/40-46 Nestor Drive Meadowbrook, 4131 QLD, Logan Australia Agenda: To consider receiving the Company's annual accounts for the financial period ended 31 December 2021, together with the directors' report and the auditors' report on those accounts; to receive and approve the directors' remuneration report for the financial period ended 31 December 2021; to reappoint Elderton Audit UK (formerly known as Greenwich & Co UK) as auditors to hold office from the conclusion of this meeting until the conclusion of the next general meeting of the Company; to authorize the directors to fix the remuneration of the auditors; to reappoint Simon St Ledger as a director; to consider reappointing directors; and to consider such other matters.Buying Opportunity • May 11Now 29% undervaluedOver the last 90 days, the stock is up 141%. The fair value is estimated to be €0.075, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.7% over the last 3 years. Meanwhile, the company became loss making.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Buying Opportunity • Mar 11Now 27% undervalued after recent price dropOver the last 90 days, the stock is down 37%. The fair value is estimated to be AU$0.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.7% per annum over the last 3 years. The company became loss making over the last 3 years.Buying Opportunity • Feb 24Now 26% undervalued after recent price dropOver the last 90 days, the stock is down 36%. The fair value is estimated to be AU$0.068, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.7% per annum over the last 3 years. The company became loss making over the last 3 years.分析記事 • Feb 16Calculating The Intrinsic Value Of Rapid Nutrition PLC (EPA:ALRPD)Does the February share price for Rapid Nutrition PLC ( EPA:ALRPD ) reflect what it's really worth? Today, we will...お知らせ • Feb 09Rapid Nutrition Announces New Distribution and Flavor OfferingsRapid Nutrition PLC has responded to increased demand for organic health and wellness offerings with new distribution and flavor offerings. Rapid Nutrition, a natural healthcare company focused on evidenced-based nutrition, diet management and life sciences products with growing worldwide distribution, is expanding its product offerings and continued growth in distribution, now sharing its organic health and wellness products throughout Australia, Asia, Europe, North America, EMEA as well as through its ecommerce channels. New brand extensions include: New mocha flavor for the popular high-protein meal replacements, which are also available in vanilla and chocolate. Coffee flavors continue to grow in popularity worldwide P.M. Protein Powder to curb late-night snacking urgers while also supporting a better night’s sleep. With 26 grams of protein per serving and a decadent Black Forest Cake flavor, this excellent source of protein and calcium caseinate includes enzymatically treated whey concentrate which results in a larger protein molecule that takes six hours longer to metabolize than typical whey protein. This allows for a slower release of aminos to support satiety and sleep. It also includes rutaecarpine, a botanical extract known as the anti-caffeine, to promote a sense of calm as well as tart cherry, a source of naturally occurring melatonin, and L-Theanine and L-Glutamine, amino acids that play an important role in sleep as precursors to sleep-inducing hormones. Two new bars added to the SystemLS range: Keto Cookie Dough Delight Whey Protein Bar and Keto Vegan Peanut Butter Brownie Plant Protein Bar. Both bars, formulated for Keto and high-protein diets, include high quality protein and are 100% natural with no artificial flavors or ingredients. The vegan bar and whey-based bar are designed to capture consumers interested in vegan products as well as those who prefer more traditional whey-based protein bars. New ingredients for the popular vegan proteins. Designed to further enhance the company’s popular vegan protein powders, include a new form of pea protein which has been fermented with mushrooms to enhance bioavailability and absorption and improve flavor while reducing GI disturbances. A customized blend of digestive enzymes eliminates the bloat that can accompany some high-protein products currently available on the market. In addition, these product updates and innovations all come with new-look sustainable packaging as part of Rapid Nutrition’s Corporate Social Responsibility commitments.株主還元ALRPDFR Personal ProductsFR 市場7D108.9%-1.9%-0.2%1Y-1.3%-0.3%1.8%株主還元を見る業界別リターン: ALRPD過去 1 年間で-0.3 % のリターンをもたらしたFrench Personal Products業界と一致しました。リターン対市場: ALRPDは、過去 1 年間で1.8 % のリターンを上げたFrench市場を下回りました。価格変動Is ALRPD's price volatile compared to industry and market?ALRPD volatilityALRPD Average Weekly Movement19.7%Personal Products Industry Average Movement4.9%Market Average Movement4.7%10% most volatile stocks in FR Market10.4%10% least volatile stocks in FR Market2.5%安定した株価: ALRPDの株価は、 French市場と比較して過去 3 か月間で変動しています。時間の経過による変動: ALRPDの weekly volatility ( 20% ) は過去 1 年間安定していますが、依然としてFrenchの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト20013Simon St. Ledgerwww.rnplc.comラピッドニュートリション社は、科学的根拠に基づいた健康食品を開発し、世界中に販売しているナチュラルヘルスケア企業である。同社は、System LSブランドで減量用にデザインされた天然成分やオーガニック成分を、Azureneブランドで喉の痛みや風邪、インフルエンザの症状に効く漢方薬や、旅行者向けに免疫力を高めるアシュワガンダやアンドログラフィスを加えた製品を提供している。また、第三者ブランドの製品も提供している。ラピッドニュートリションPLCは2001年に設立され、イギリスのミルデンホールに本社を置いている。もっと見るRapid Nutrition PLC 基礎のまとめRapid Nutrition の収益と売上を時価総額と比較するとどうか。ALRPD 基礎統計学時価総額€3.23m収益（TTM）-€1.91m売上高(TTM)€119.51k27.1xP/Sレシオ-1.7xPER（株価収益率ALRPD は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計ALRPD 損益計算書（TTM）収益AU$194.33k売上原価AU$141.40k売上総利益AU$52.93kその他の費用AU$3.15m収益-AU$3.10m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-6.53グロス・マージン27.24%純利益率-1,596.11%有利子負債／自己資本比率0.9%ALRPD の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/27 03:10終値2026/07/27 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Rapid Nutrition PLC 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Longdley ZephirinZephirin Group, Inc.
お知らせ • Jun 02Rapid Nutrition Expands Agentic AI Integration Across Consumer Wellness EcosystemRapid Nutrition PLC has progressively expanded the rollout of its technology-enabled engagement platform across investor communications, consumer wellness interactions and broader digital operations as part of its strategy to build a scalable HealthTech ecosystem at the intersection of nutrition, technology and consumer behaviour. Following the initial deployment across investor communications, Rapid Nutrition has observed improved accessibility and responsiveness, with investor enquiries increasingly being addressed in near real-time across multiple time zones. The Company has since expanded the platform across elements of its consumer ecosystem, including the Company’s flagship SystemLS brand, where early-stage engagement trends indicate increasing interaction with product, wellness and lifestyle-aligned content tailored to individual user interests and behaviours. Rapid Nutrition believes the application of artificial intelligence and agentic capabilities enables a transition from static information delivery toward more responsive, real-time and personalized engagement across both investor and consumer channels. The platform has been developed using Company materials and operational frameworks and continues to be refined by Rapid Nutrition’s experienced team to ensure alignment with the Company’s products, communication standards and broader wellness ecosystem.
お知らせ • May 13Rapid Nutrition plc Expands AI-Powered Agentic Platform to Consumer EcosystemRapid Nutrition PLC announced the expansion of its technology platform to its consumer-facing ecosystem, following a successful rollout within its investor communications infrastructure. The Company is extending these capabilities across its flagship SystemLS brand, enabling a more responsive and personalized approach to consumer health and wellness engagement. The platform delivers structured, on-demand guidance across nutrition, products, and lifestyle — available 24/7 in a private, confidential environment. As consumer expectations increasingly flavor personalized health solutions, the system is designed to translate product and nutritional information into practical, everyday guidance aligned to individual habits and routines. Trained on Company materials and informed by Rapid Nutrition’s experienced team, the platform ensures all responses reflect the Company’s product philosophy, nutritional methodologies, and established wellness programs. The system is designed to complement, not replace, professional human interaction — extending access to practitioner-informed guidance while maintaining alignment with the Company’s personalised nutrition approach. It supports consumer education only and does not constitute professional medical advice. This expansion represents a continued step in Rapid Nutrition’s strategy to deploy advanced technologies — including artificial intelligence and agentic capabilities — across both its corporate and consumer operations, driving deeper and more consistent engagement with long-term wellness programs.
Reported Earnings • Apr 30Full year 2025 earnings released: AU$0.01 loss per share (vs AU$38.10 loss in FY 2024)Full year 2025 results: AU$0.01 loss per share. Net loss: AU$3.10m (loss widened 6.8% from FY 2024).
お知らせ • Apr 22Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia.Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia on April 20, 2026. The transaction is subject to consummation of due diligence investigation and final documentation.
Board Change • Apr 13Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Buy Or Sell Opportunity • Feb 10Now 29% undervaluedOver the last 90 days, the stock has risen 237% to €10.12. The fair value is estimated to be €14.25, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
お知らせ • Jun 02Rapid Nutrition Expands Agentic AI Integration Across Consumer Wellness EcosystemRapid Nutrition PLC has progressively expanded the rollout of its technology-enabled engagement platform across investor communications, consumer wellness interactions and broader digital operations as part of its strategy to build a scalable HealthTech ecosystem at the intersection of nutrition, technology and consumer behaviour. Following the initial deployment across investor communications, Rapid Nutrition has observed improved accessibility and responsiveness, with investor enquiries increasingly being addressed in near real-time across multiple time zones. The Company has since expanded the platform across elements of its consumer ecosystem, including the Company’s flagship SystemLS brand, where early-stage engagement trends indicate increasing interaction with product, wellness and lifestyle-aligned content tailored to individual user interests and behaviours. Rapid Nutrition believes the application of artificial intelligence and agentic capabilities enables a transition from static information delivery toward more responsive, real-time and personalized engagement across both investor and consumer channels. The platform has been developed using Company materials and operational frameworks and continues to be refined by Rapid Nutrition’s experienced team to ensure alignment with the Company’s products, communication standards and broader wellness ecosystem.
お知らせ • May 13Rapid Nutrition plc Expands AI-Powered Agentic Platform to Consumer EcosystemRapid Nutrition PLC announced the expansion of its technology platform to its consumer-facing ecosystem, following a successful rollout within its investor communications infrastructure. The Company is extending these capabilities across its flagship SystemLS brand, enabling a more responsive and personalized approach to consumer health and wellness engagement. The platform delivers structured, on-demand guidance across nutrition, products, and lifestyle — available 24/7 in a private, confidential environment. As consumer expectations increasingly flavor personalized health solutions, the system is designed to translate product and nutritional information into practical, everyday guidance aligned to individual habits and routines. Trained on Company materials and informed by Rapid Nutrition’s experienced team, the platform ensures all responses reflect the Company’s product philosophy, nutritional methodologies, and established wellness programs. The system is designed to complement, not replace, professional human interaction — extending access to practitioner-informed guidance while maintaining alignment with the Company’s personalised nutrition approach. It supports consumer education only and does not constitute professional medical advice. This expansion represents a continued step in Rapid Nutrition’s strategy to deploy advanced technologies — including artificial intelligence and agentic capabilities — across both its corporate and consumer operations, driving deeper and more consistent engagement with long-term wellness programs.
Reported Earnings • Apr 30Full year 2025 earnings released: AU$0.01 loss per share (vs AU$38.10 loss in FY 2024)Full year 2025 results: AU$0.01 loss per share. Net loss: AU$3.10m (loss widened 6.8% from FY 2024).
お知らせ • Apr 22Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia.Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia on April 20, 2026. The transaction is subject to consummation of due diligence investigation and final documentation.
Board Change • Apr 13Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Buy Or Sell Opportunity • Feb 10Now 29% undervaluedOver the last 90 days, the stock has risen 237% to €10.12. The fair value is estimated to be €14.25, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
Buy Or Sell Opportunity • Jan 22Now 35,009% overvalued after recent price riseOver the last 90 days, the stock has risen 124,224% to €4.60. The fair value is estimated to be €0.013, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 41% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Jan 05Rapid Nutrition PLC announced that it has received €5 million in fundingRapid Nutrition PLC announced a private placement of common shares for gross proceeds of €5 million on January 5, 2026.
Reported Earnings • Oct 29First half 2025 earnings released: EPS: AU$0 (vs AU$0 in 1H 2024)First half 2025 results: EPS: AU$0 (in line with 1H 2024). Revenue: AU$113.1k (down 59% from 1H 2024). Net loss: AU$1.65m (loss narrowed 17% from 1H 2024). Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Personal Products industry in Europe.
New Risk • Oct 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 17% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 7x increase in shares outstanding). Revenue is less than US$1m (AU$917k revenue, or US$594k). Market cap is less than US$10m (€2.14m market cap, or US$2.50m). Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Share price has been volatile over the past 3 months (9.7% average weekly change).
New Risk • Dec 13New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.9m free cash flow). Share price has been highly volatile over the past 3 months (41% average weekly change). Earnings have declined by 34% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 18x increase in shares outstanding). Revenue is less than US$1m (AU$1.3m revenue, or US$816k). Market cap is less than US$10m (€3.19m market cap, or US$3.35m).
Reported Earnings • Oct 24First half 2024 earnings releasedFirst half 2024 results: EPS: AU$0. Revenue: AU$276.1k (down 58% from 1H 2023). Net loss: AU$1.99m (loss widened 117% from 1H 2023). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Personal Products industry in Europe.
Reported Earnings • May 01Full year 2023 earnings released: AU$0.001 loss per share (vs AU$18.64 loss in FY 2022)Full year 2023 results: AU$0.001 loss per share (improved from AU$18.64 loss in FY 2022). Revenue: AU$1.66m (down 44% from FY 2022). Net loss: AU$2.02m (loss narrowed 80% from FY 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe.
New Risk • Apr 28New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (28% average weekly change). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 39x increase in shares outstanding). Market cap is less than US$10m (€1.43m market cap, or US$1.53m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Revenue is less than US$5m (AU$3.2m revenue, or US$2.1m).
New Risk • Oct 18New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.0m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.0m free cash flow). Share price has been highly volatile over the past 3 months (34% average weekly change). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 6x increase in shares outstanding). Market cap is less than US$10m (€482.9k market cap, or US$508.5k). Minor Risk Revenue is less than US$5m (AU$3.2m revenue, or US$2.1m).
New Risk • Jun 29New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (53% average weekly change). Earnings have declined by 56% per year over the past 5 years. Shareholders have been substantially diluted in the past year (162% increase in shares outstanding). Market cap is less than US$10m (€374.5k market cap, or US$408.8k). Minor Risk Revenue is less than US$5m (AU$3.0m revenue, or US$2.0m).
Reported Earnings • Jun 29Full year 2022 earnings released: AU$0.002 loss per share (vs AU$0.005 profit in FY 2021)Full year 2022 results: AU$0.002 loss per share (down from AU$0.005 profit in FY 2021). Revenue: AU$2.96m (down 1.5% from FY 2021). Net loss: AU$9.97m (down AU$10.2m from profit in FY 2021). Revenue is forecast to grow 7.9% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 05First half 2022 earnings released: EPS: AU$0.007 (vs AU$0.009 in 1H 2021)First half 2022 results: EPS: AU$0.007. Revenue: AU$1.99m (up 42% from 1H 2021). Net income: AU$1.07m (up 196% from 1H 2021). Profit margin: 54% (up from 26% in 1H 2021). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Personal Products industry in Europe.
お知らせ • May 31Rapid Nutrition PLC (ENXTPA:ALRPD) acquired Silveraxe LLP for approximately USD 0.75 million.Rapid Nutrition PLC (ENXTPA:ALRPD) acquired Silveraxe LLP for approximately USD 0.75 million on May 30, 2022. Rapid Nutrition PLC (ENXTPA:ALRPD) completed the acquisition of Silveraxe LLP on May 30, 2022.
お知らせ • May 25Rapid Nutrition PLC, Annual General Meeting, Jun 30, 2022Rapid Nutrition PLC, Annual General Meeting, Jun 30, 2022, at 21:00 Coordinated Universal Time. Location: 2/40-46 Nestor Drive Meadowbrook, 4131 QLD, Logan Australia Agenda: To consider receiving the Company's annual accounts for the financial period ended 31 December 2021, together with the directors' report and the auditors' report on those accounts; to receive and approve the directors' remuneration report for the financial period ended 31 December 2021; to reappoint Elderton Audit UK (formerly known as Greenwich & Co UK) as auditors to hold office from the conclusion of this meeting until the conclusion of the next general meeting of the Company; to authorize the directors to fix the remuneration of the auditors; to reappoint Simon St Ledger as a director; to consider reappointing directors; and to consider such other matters.
Buying Opportunity • May 11Now 29% undervaluedOver the last 90 days, the stock is up 141%. The fair value is estimated to be €0.075, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.7% over the last 3 years. Meanwhile, the company became loss making.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Buying Opportunity • Mar 11Now 27% undervalued after recent price dropOver the last 90 days, the stock is down 37%. The fair value is estimated to be AU$0.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.7% per annum over the last 3 years. The company became loss making over the last 3 years.
Buying Opportunity • Feb 24Now 26% undervalued after recent price dropOver the last 90 days, the stock is down 36%. The fair value is estimated to be AU$0.068, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.7% per annum over the last 3 years. The company became loss making over the last 3 years.
分析記事 • Feb 16Calculating The Intrinsic Value Of Rapid Nutrition PLC (EPA:ALRPD)Does the February share price for Rapid Nutrition PLC ( EPA:ALRPD ) reflect what it's really worth? Today, we will...
お知らせ • Feb 09Rapid Nutrition Announces New Distribution and Flavor OfferingsRapid Nutrition PLC has responded to increased demand for organic health and wellness offerings with new distribution and flavor offerings. Rapid Nutrition, a natural healthcare company focused on evidenced-based nutrition, diet management and life sciences products with growing worldwide distribution, is expanding its product offerings and continued growth in distribution, now sharing its organic health and wellness products throughout Australia, Asia, Europe, North America, EMEA as well as through its ecommerce channels. New brand extensions include: New mocha flavor for the popular high-protein meal replacements, which are also available in vanilla and chocolate. Coffee flavors continue to grow in popularity worldwide P.M. Protein Powder to curb late-night snacking urgers while also supporting a better night’s sleep. With 26 grams of protein per serving and a decadent Black Forest Cake flavor, this excellent source of protein and calcium caseinate includes enzymatically treated whey concentrate which results in a larger protein molecule that takes six hours longer to metabolize than typical whey protein. This allows for a slower release of aminos to support satiety and sleep. It also includes rutaecarpine, a botanical extract known as the anti-caffeine, to promote a sense of calm as well as tart cherry, a source of naturally occurring melatonin, and L-Theanine and L-Glutamine, amino acids that play an important role in sleep as precursors to sleep-inducing hormones. Two new bars added to the SystemLS range: Keto Cookie Dough Delight Whey Protein Bar and Keto Vegan Peanut Butter Brownie Plant Protein Bar. Both bars, formulated for Keto and high-protein diets, include high quality protein and are 100% natural with no artificial flavors or ingredients. The vegan bar and whey-based bar are designed to capture consumers interested in vegan products as well as those who prefer more traditional whey-based protein bars. New ingredients for the popular vegan proteins. Designed to further enhance the company’s popular vegan protein powders, include a new form of pea protein which has been fermented with mushrooms to enhance bioavailability and absorption and improve flavor while reducing GI disturbances. A customized blend of digestive enzymes eliminates the bloat that can accompany some high-protein products currently available on the market. In addition, these product updates and innovations all come with new-look sustainable packaging as part of Rapid Nutrition’s Corporate Social Responsibility commitments.
